AUREUM DIAGNOSTICS LIMITED

🏛️Establishedactive
13201459 · ltd · incorporated 2021-02-15
Investment thesis
Established operating company — standard diligence applies, no dominant angle.
Why interesting: Live, filing, normal profile.
Why risky: No standout signals in either direction.
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£293.1k
book net assets
Opportunity
76/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: Research and experimental development on biotechnology
Sector: Professional, scientific & technical
Investor take
Pursue
Strong opportunity: asset-holding vehicle with strong profile and bankable structure.

Opportunity 76/100 (strong), bankability 75/100. Share purchase looks the cleaner deal structure. Biggest value-creation lever: Cash flow review and working-capital discipline. Cash down -60% YoY — forensic review of receivables, stock turns, and creditor days. Most likely exit: share sale to pe / searcher (65/100).

Data confidence

Overall: high (81/100)

Strong data coverage across all sections. AI outputs should be trusted with minimal caveats.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
11 officers (6 active, 11 linked, 10 with DOB)
88
Ownership & PSC
0 active PSC(s) of 4 total, 4 with control declared
90
Director network
8 connected companies via shared directors
69
Filing history
69 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
76/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
65
Adequate — check latest filings for context.
Acquirability
70
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 102
Positive net assets
Net assets £293,068
Net assets shrinking
Down £498,659 YoY
Cash draining
Cash down 60% YoY
Cash YoY
-60%
Year on year

Key financials

2 years extracted from filed iXBRL accounts
Cash
£278k
↓ 60% YoY
Net Worth
£293k
↓ 63% YoY
Current Assets
£572k
↓ 36% YoY
Current Liabilities
£0£179k£358k£537k£716k£894kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 102
Metric2025-03-312024-03-31
Total assets£293.2k£791.7k
Current assets£571.8k£894.5k
Cash£278.0k£702.5k
Debtors£293.9k£192.0k
Net assets£293.1k£791.7k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

2 signals detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
6
filings
  • 6 miscellaneous
Last 90 days
8
filings
  • 6 miscellaneous
  • 1 capital
  • 1 confirmation-statement
Last 180 days
8
filings
  • 6 miscellaneous
  • 1 capital
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (40 events)Click to expand
  1. 2026-06-08
    📄
    legacy
    miscellaneous · RP01SH01
  2. 2026-06-08
    📄
    legacy
    miscellaneous · RP01SH01
  3. 2026-06-05
    📄
    legacy
    miscellaneous · RP01SH01
  4. 2026-06-05
    📄
    legacy
    miscellaneous · RP01SH01
  5. 2026-06-05
    📄
    legacy
    miscellaneous · RP01SH01
  6. 2026-06-05
    📄
    legacy
    miscellaneous · RP01SH01
  7. 2026-04-01
    📄
    capital-allotment-shares
    capital · SH01
  8. 2025-09-23
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  9. 2025-04-04
    📄
    second-filing-capital-allotment-shares
    capital · RP04SH01
  10. 2025-04-04
    📄
    second-filing-capital-allotment-shares
    capital · RP04SH01
  11. 2025-04-03
    📄
    capital-allotment-shares
    capital · SH01
  12. 2025-04-03
    📄
    capital-allotment-shares
    capital · SH01
  13. 2025-03-22
    📄
    notification-of-a-person-with-significant-control-statement
    persons-with-significant-control · PSC08
  14. 2025-02-25
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  15. 2025-01-22
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  16. 2025-01-16
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  17. 2025-01-16
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  18. 2025-01-16
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  19. 2025-01-08
    REYNOLDS, Patricia Elaine appointed
    director
  20. 2025-01-06
    LONGMUIR, Alistair David appointed
    director
  21. 2025-01-06
    ROBERTS-MCINTOSH, Alexis Shona, Dr resigned
    director
  22. 2025-01-06
    SHILLINGFORD, John, Dr resigned
    director
  23. 2024-11-01
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  24. 2024-08-22
    📄
    capital-allotment-shares
    capital · SH01
  25. 2024-07-31
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  26. 2024-07-30
    DAVIES, Oliver William Hardwicke, Dr. resigned
    director
  27. 2024-03-18
    📄
    appoint-person-director-company-with-name-date
    officers · AP01
  28. 2024-03-18
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  29. 2024-03-06
    HEGARTY, Mark, Dr appointed
    director
  30. 2024-03-06
    HOWELL, Steven, Professor resigned
    director
  31. 2023-03-28
    OGLE, Tessa Maree appointed
    director
  32. 2022-11-10
    OGLE, Tessa Maree appointed
    secretary
  33. 2022-10-06
    ROBERTS-MCINTOSH, Alexis Shona, Dr appointed
    director
  34. 2021-10-08
    CORRIGAN, Damion Kevin, Dr appointed
    director
  35. 2021-10-08
    DAVIES, Oliver William Hardwicke, Dr. appointed
    director
  36. 2021-10-08
    HOWELL, Steven, Professor appointed
    director
  37. 2021-10-08
    REYNOLDS, Patricia Elaine resigned
    director
  38. 2021-10-08
    SHILLINGFORD, John, Dr appointed
    director
  39. 2021-02-15
    🏢
    Company incorporated
    As AUREUM DIAGNOSTICS LIMITED
  40. 2021-02-15
    REYNOLDS, Patricia Elaine appointed
    director

Owner dependency

55/100
Moderate — manageable with handover

Some founder dependency, but not acute. A structured handover period should cover most risk.

FACTORS
  • -5 active directors: Broader management team in place — suggests transferable governance.
  • +Founder age: Director aged approximately 65 — succession pressure is live.

Succession & seller-readiness

50/100
Moderate signal

Some succession indicators present. Worth watching; approach if sector/strategy fits.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 65. Approaching typical UK retirement age — succession thinking likely.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)
🔒Co-director network graph

Radial SVG graph showing every company connected via shared directors, colour-coded by status.

Available from the Pro tier upwards.

See pricing →

Similar companies

Active · Professional services · W postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
AD STREVA LIMITED
16415252 · est 2025 · no financials extracted
ADDERE CAPITAL LTD
12808837 · est 2020 · no financials extracted
5y
ADDITION DESIGN OFFICE LTD
14579481 · est 2023 · no financials extracted
3y
ADEPT SOURCING LTD.
10114891 · est 2016 · no financials extracted
10y
ADESTER TRADING LIMITED
07811512 · est 2011 · no financials extracted
14y
ADFYM LTD
14534624 · est 2022 · no financials extracted
3y
ADHD VENTURES LTD
16951631 · est 2026 · no financials extracted
ADIA BATIC COLLABORATION LTD
16913885 · est 2025 · no financials extracted
ADIB ENTERPRISES LTD
12721497 · est 2020 · no financials extracted
5y
ADIGNITY LIMITED
13344618 · est 2021 · no financials extracted
4y
ADK BUSINESS CONSULTING LTD
08575042 · est 2013 · no financials extracted
12y
ADMATT CONSULTING LTD
09937405 · est 2016 · no financials extracted
10y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2021-02-15
Jurisdictionengland-wales
Primary SIC72110 — Research and experimental development on biotechnology

Registered office

First Floor 85, Great Portland Street
London
W1W 7LT
England

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-02-28
Last: 2026-02-14

Officers (6 active · 5 resigned)

OGLE, Tessa Maree
secretary · appointed 2022-11-10
View their other companies + combined net worth →
Active
CORRIGAN, Damion Kevin, Dr
director · ~47y · appointed 2021-10-08
View their other companies + combined net worth →
Active
HEGARTY, Mark, Dr
director · ~65y · appointed 2024-03-06
View their other companies + combined net worth →
Active
LONGMUIR, Alistair David
director · ~56y · appointed 2025-01-06
View their other companies + combined net worth →
Active
OGLE, Tessa Maree
director · ~41y · appointed 2023-03-28
View their other companies + combined net worth →
Active
REYNOLDS, Patricia Elaine
director · ~50y · appointed 2025-01-08
View their other companies + combined net worth →
Active
DAVIES, Oliver William Hardwicke, Dr.
director · ~57y · appointed 2021-10-08 · resigned 2024-07-30
Resigned
HOWELL, Steven, Professor
director · ~59y · appointed 2021-10-08 · resigned 2024-03-06
Resigned
REYNOLDS, Patricia Elaine
director · ~50y · appointed 2021-02-15 · resigned 2021-10-08
Resigned
ROBERTS-MCINTOSH, Alexis Shona, Dr
director · ~64y · appointed 2022-10-06 · resigned 2025-01-06
Resigned
SHILLINGFORD, John, Dr
director · ~77y · appointed 2021-10-08 · resigned 2025-01-06
Resigned

Click a director name to see their full track record across all companies.

Recent filings (69 total)

legacy
miscellaneous · RP01SH01
2026-06-08
legacy
miscellaneous · RP01SH01
2026-06-08
legacy
miscellaneous · RP01SH01
2026-06-05
legacy
miscellaneous · RP01SH01
2026-06-05
legacy
miscellaneous · RP01SH01
2026-06-05
legacy
miscellaneous · RP01SH01
2026-06-05
capital-allotment-shares
capital · SH01
2026-04-01
confirmation-statement-with-updates
confirmation-statement · CS01
2026-04-01
accounts-with-accounts-type-total-exemption-full
accounts · AA
2025-09-23
second-filing-capital-allotment-shares
capital · RP04SH01
2025-04-04
second-filing-capital-allotment-shares
capital · RP04SH01
2025-04-04
capital-allotment-shares
capital · SH01
2025-04-03
capital-allotment-shares
capital · SH01
2025-04-03
notification-of-a-person-with-significant-control-statement
persons-with-significant-control · PSC08
2025-03-22
confirmation-statement-with-updates
confirmation-statement · CS01
2025-02-25